Abstract : Background: Inflammation and immune-mediated reactions are facilitated by the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1). In patients with coronavirus disease 2019 (COVID-19), viral infection of endothelial cells brought on by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can result in vascular alterations and boost the expression of ICAM-1, and may be utilized as a biomarker to assess disease severity. The purpose of this study was to determine how serum ICAM-1 levels affected the severity and prognosis of COVID-19. Materials and Methods: 120 patients with COVID-19 participated in the research. According to the severity of the condition, the COVID-19 patients were divided into three groups: critical disease (n = 23), severe disease (n = 37), and mild/moderate disease (n = 60), with 60 healthy volunteers working as the control group. Blood samples were taken as well as all of the patients' fundamental clinical and demographic information.

Volume and Issue
Full Article Download